These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33851515)

  • 21. The genetics of paragangliomas: a review.
    Martin TP; Irving RM; Maher ER
    Clin Otolaryngol; 2007 Feb; 32(1):7-11. PubMed ID: 17298303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.
    Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X
    Diagn Mol Pathol; 2005 Jun; 14(2):109-14. PubMed ID: 15905695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penetrance and clinical consequences of a gross SDHB deletion in a large family.
    Solis DC; Burnichon N; Timmers HJ; Raygada MJ; Kozupa A; Merino MJ; Makey D; Adams KT; Venisse A; Gimenez-Roqueplo AP; Pacak K
    Clin Genet; 2009 Apr; 75(4):354-63. PubMed ID: 19389109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial paraganglioma syndrome: phenotype and relevance of a new SDHB mutation].
    Díaz-Soto G; Serrano Morte A; Rodríguez Martín C; García-Talavera P; Abril CM; Puig-Domingo M
    Med Clin (Barc); 2013 May; 140(10):453-7. PubMed ID: 23434467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the association of succinate dehydrogenase mutations with hereditary paraganglioma.
    Baysal BE
    Trends Endocrinol Metab; 2003 Dec; 14(10):453-9. PubMed ID: 14643060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular progress in hereditary paraganglioma.
    Baysal BE
    J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the SDHB and SDHD genes.
    Pawlu C; Bausch B; Neumann HP
    Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
    Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
    Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Risk of Corporal Tumors in Patients With Head and Neck Paragangliomas With p.Pro81Leu Mutations.
    Miller KM; Sbeih F; Contrera K; Reddy CA; Marquard J; Eng C; Lorenz RR
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):570-576. PubMed ID: 36939592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
    Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
    Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation.
    Pigny P; Vincent A; Cardot Bauters C; Bertrand M; de Montpreville VT; Crepin M; Porchet N; Caron P
    J Clin Endocrinol Metab; 2008 May; 93(5):1609-15. PubMed ID: 18211978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.
    Foley M; Sharma A; Garfield K; Maese L; Buchmann L; Boyle J; Kohlmann W; Jeter J; Greenberg S
    Fam Cancer; 2023 Apr; 22(2):217-224. PubMed ID: 36223042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mutation in the SDHD gene in a family with inherited paragangliomas--implications of genetic diagnosis for follow up and treatment.
    Renard L; Godfraind C; Boon LM; Vikkula M
    Head Neck; 2003 Feb; 25(2):146-51. PubMed ID: 12509798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
    Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
    Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial paraganglioma syndrome: applying genetic screening in otolaryngology.
    Dziegielewski PT; Knox A; Liu R; Hung RW; Harris J
    J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):646-53. PubMed ID: 21144359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.
    Hermsen MA; Sevilla MA; Llorente JL; Weiss MM; Grimbergen A; Allonca E; Garcia-Inclán C; Balbín M; Suárez C
    Cell Oncol; 2010 Jan; 32(4):275-83. PubMed ID: 20208144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.